150 related articles for article (PubMed ID: 20564150)
41. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
[TBL] [Abstract][Full Text] [Related]
42. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
43. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
[TBL] [Abstract][Full Text] [Related]
44. [Clinical study on the effect of intra-arterial injection of mitoxantrone-lipiodol emulsion for hepatocellular carcinoma].
Ichikawa W; Togo S; Osanai T; Miyanaga T; Sawai S; Yamashita T; Kawachi Y; Nihei Z; Hirayama R; Mishima Y
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2212-4. PubMed ID: 7944442
[TBL] [Abstract][Full Text] [Related]
45. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
46. [Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol)].
Kajiya Y; Nakajo M; Kobayashi H; Oyama T; Shinohara S
Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):815-21. PubMed ID: 2849622
[No Abstract] [Full Text] [Related]
47. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
48. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP
Radiology; 2007 May; 243(2):509-19. PubMed ID: 17456873
[TBL] [Abstract][Full Text] [Related]
49. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
Werenne X
Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
[TBL] [Abstract][Full Text] [Related]
50. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
[TBL] [Abstract][Full Text] [Related]
51. [Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol].
Kobayashi H; Nakajo M; Shimabukuro K; Shirono K; Sakata H; Oyama T; Sonoda T; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):96-8. PubMed ID: 6330667
[No Abstract] [Full Text] [Related]
52. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
Lau WY; Leung TW; Ho SK; Chan M; Machin D; Lau J; Chan AT; Yeo W; Mok TS; Yu SC; Leung NW; Johnson PJ
Lancet; 1999 Mar; 353(9155):797-801. PubMed ID: 10459961
[TBL] [Abstract][Full Text] [Related]
53. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
[TBL] [Abstract][Full Text] [Related]
54. Internal radiation by 131-iodine lipiodol in unresectable hepatocellular carcinoma.
Tabone M; Carbonatto P; Calvo A; Pellerito R; Stasi M; Daperno M; Rocca R
Dig Liver Dis; 2013 Nov; 45(11):962-3. PubMed ID: 23587497
[No Abstract] [Full Text] [Related]
55. Hepatocellular carcinoma; treatment with a radioiodinated fatty acid ester.
Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Choi HJ; Madsen MT
Yonsei Med J; 1988; 29(2):166-75. PubMed ID: 2851226
[No Abstract] [Full Text] [Related]
56. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
[No Abstract] [Full Text] [Related]
57. Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. A single-center study based on a long-term follow-up.
Ahmadzadehfar H; Habibi E; Ezziddin S; Wilhelm K; Fimmers R; Spengler U; Palmedo H; Strunk H; Schild HH; Biersack HJ; Risse J
Nuklearmedizin; 2014; 53(2):46-53. PubMed ID: 24468919
[TBL] [Abstract][Full Text] [Related]
58. Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysis.
Chua TC; Saxena A; Chu F; Butler SP; Quinn RJ; Glenn D; Morris DL
Int J Clin Oncol; 2011 Apr; 16(2):125-32. PubMed ID: 21061140
[TBL] [Abstract][Full Text] [Related]
59. Hepatocellular carcinoma with skeletal metastasis: management with intraarterial radioactive iodine.
Cho YD; Yum HY; Park YH
J Belge Radiol; 1989 Aug; 72(4):267-71. PubMed ID: 2551883
[TBL] [Abstract][Full Text] [Related]
60. Intraarterial HCC therapy with I-131-Lipiodol.
Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]